Therapeutics: Aryl hydrocarbon receptor (AHR)

Endocrine/metabolic disease

INDICATION: Diabetes

Mouse studies suggest nanoparticles loaded with an

Read the full 90 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE